Utilization of hematopoietic cell transplantation and cellular therapy technology in Europe and associated Countries. Using the 2022 activity survey data to correlate with economic and demographic factors. A report from the EBMT
Sign Up to like & getrecommendations! Published in 2024 at "Bone Marrow Transplantation"
DOI: 10.1038/s41409-024-02459-0
Abstract: We looked at treatment rates and center density across countries for patients treated in 2022; 46,143 HCTs (19,011 (41.2%) allogeneic, 27,132 (58.8%) autologous) reported by 689 centers. 4329 patients received advanced cellular therapies, 3205 were… read more here.
Keywords: utilization hematopoietic; use; allogeneic hct; hct ... See more keywords